Skip to main content
SpringerLink
Log in

Pneumokokkenimpfung bei immunsupprimierten Patienten

Aktuelle Empfehlungen

Pneumococcus vaccination in immunosuppressed patients

Current recommendations

  • Hot Topics
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Aqua Qualitätsreprt (2011) http://www.sqg.uppload/CONTENT/Qualitaesberichte/2011/AQUA-Qualitaetsreport-2011.pdf

  2. Pletz MW, Rohde G, Schütte H et al (2011) Epidemiology and aetiology of Community-acquired Pneumonia (CAP). Dtsch Med wochenschr 136:775–780

    Article  PubMed  CAS  Google Scholar 

  3. Ewig S, Birkner N, Strauss R et al (2009) New perspectives on community-acquired pneumonia in 388,406 patients. Results from a nationwide mandatory performance measurement programme in health quality. Thorax 64:1062–1069

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Smitten AL, Choi HK, Hochberg MC et al (2008) The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol 35:387–393

    PubMed  Google Scholar 

  5. Kinder BW, Freemer MM, King TE Jr et al (2007) Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus. Arthritis Rheum 56:2679–2686

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Höffken G, Lorenz J, Kern W et al (2005) S3-Leitlinie zu Epidemiologie, Diagnostik, antimikrobieller Therapie und Management von erwachsenen Patienten mit ambulant erworbenen tiefen Atemwegsinfektionen. Pneumologie 59:612–664

    Article  PubMed  Google Scholar 

  7. Strangfeld A, Eveslage M, Schneider M et al (2011) Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient? Ann Rheum Dis 70:1914–1920

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Coulson E, Saravanan V, Hamilton J et al (2011) Pneumoccocal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate. Ann Rheum Dis 70:1289–1291

    Article  PubMed  CAS  Google Scholar 

  9. Van Assen S, Agmon-Levin N, Elkayam O et al (2011) EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 70:414–422

    Article  CAS  Google Scholar 

  10. Warnatz K, Goldacker S, Gause AM und die Kommission Pharmakotherapie der DGRh (2013) Impfempfehlungen der Kommission für Pharmakotherapie der DGRh. Z Rheumatol 72. doi:10.1007/s00393–013-1154-5, (im Druck)

  11. Kapetanovic MC, Roseman C, Jönsson G et al (2011) Antibody response Is reduced Following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors. Arthritis Rheum 63:3723–3732

    Article  PubMed  CAS  Google Scholar 

  12. Kapetanovic MC, Saxne T, Sjöholm A et al (2006) Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology 45:106–111

    Article  PubMed  CAS  Google Scholar 

  13. Tay L, Leon F, Vratsanos G et al (2007) Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects. Arthritis Res Ther 9:R38

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Mori S, Ueki Y, Akeda Y et al (2013) Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy. Ann Rheum Dis (online January 23, 2013 as 10.1136/annrheumdis-2012–202658)

  15. Rehnberg M, Brisslert M, Amu S et al (2010) Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment. Arthritis Res Ther 12:R111

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Feuchtenberger M, Kleinert S, Schwab S et al (2012) Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study. Rheumatol Int 32:1533–1539

    Article  PubMed  Google Scholar 

  17. Desai SP, Lu B, Szent-Gyorgy LE et al (2013) Increasing pneumococcal vaccination for immunosuppressed patients: a cluster quality improvement trial. Arthritis Rheum 65:39–47

    Article  PubMed  Google Scholar 

  18. Savage J, Muller F, Ormerod AD (2011) Awareness and uptake of recommended vaccines among immunosuppressed patients. J R Coll Physicians Edinb 41:202–205

    Article  PubMed  CAS  Google Scholar 

  19. Fendler C, Saracbasi E, Dybowski F et al (2012) Praktische Probleme bei der Umsetzung von Impfempfehlungen. Z Rheumatol 71:147–155

    Article  PubMed  CAS  Google Scholar 

  20. STIKO (2012) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2012. Epidemiol Bull 30:283–309

    Google Scholar 

  21. Bundesministerium für Gesundheit (2013) Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über die Änderung der Schutzimpfungs-Richtlinie (SI-RL): Umsetzung der STIKO-Empfehlungen Juli 2012. BAnz AT 13.03.2013 B4:1–3

    Google Scholar 

  22. Gemeinsamer Bundesausschuss (2012) Tragende Gründe zum Beschluss des Gemeinsamen Bundesausschusses über die Änderung der Schutzimpfungs-Richtlinie: Umsetzung der STIKO-Empfehlung Juli 2012. http://www.gba.de/informationen/beschluesse/1582/

  23. Beier D (2012) Empfehlungen der Sächsischen Impfkommission zur Impfung Erwachsener mit Pneumokokken-Konjugatimpfstoffen. Chemother J 21:109–112

    Google Scholar 

  24. Pletz M, Ewig S, Höffken G et al (2012) Stellungnahme von Experten der PEG zum Beitrag „Empfehlungen der Sächsischen Impfkommission zur Impfung Erwachsener mit Pneumokokken-Konjugatimpfstoffen“. Chemother J 21:172–174

    Google Scholar 

  25. Moberley SA, Holden J, Tatham DP, Andrews RM (2008) Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 1:CD000422

    PubMed  Google Scholar 

  26. Pletz ME, Baum H von, Linden M van der et al (2012) The burden of pneumococcal pneumonia – experience of the German competence network CAPNETZ. Pneumologie 66:470–475

    Article  PubMed  CAS  Google Scholar 

  27. Poolman J, Borrow R (2011) Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines. Expert Rev Vaccines 10:307–322

    Article  PubMed  CAS  Google Scholar 

  28. Cohen R, Levy C, Bingen E et al (2012) Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute Otitis Media. Pediatr Infect Dis J 31:297–301

    Article  PubMed  Google Scholar 

  29. Pletz W et al (2008) Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents 32:199–206

    Article  PubMed  CAS  Google Scholar 

  30. Pilishvilli T et al (2010) Sustained reduction in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201:32–41

    Article  Google Scholar 

  31. Jackson L, Gurtman A, Cleef M van et al (2011) Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in pneumococcal vaccine naïve adults, 50–64 years of age. ECCMID; O426

  32. Paradiso P (2012) Pneumococcal conjugate vaccine for adults: a new paradigm. Clin In Dis 55(2):259–264

    Article  CAS  Google Scholar 

  33. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/001104/WC500119784.pdf

  34. STIKO (2012) Stellungnahme zur Impfung Erwachsener gegen Pneumokokken. Epidemio Bull 7:55–56

    Google Scholar 

  35. AICP (2012) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6140a4.htm und MMWR 61:816–819

    Google Scholar 

  36. http://www.neovacs.fr/en/press/publications/196 und Mitteilung auf dem 25th Annual Meeting of the French Society of Rheumatology, 10.12.2012

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. Die Autoren weisen auf folgende Beziehung hin: A. Krause und K. Krüger erhalten Vortrags- und Beratungshonorare von Pfizer Pharma GmbH. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin, Abteilung Rheumatologie und klinische Immunologie, Immanuel Krankenhaus Berlin, Königstr. 63, 14109, Berlin, Deutschland

    A. Krause

  2. Praxiszentrum, St. Bonifatiusstr. 5, 81541, München, Deutschland

    K. Krüger

Authors
  1. A. Krause
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Krüger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to A. Krause or K. Krüger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krause, A., Krüger, K. Pneumokokkenimpfung bei immunsupprimierten Patienten . Z. Rheumatol. 72, 942–946 (2013). https://doi.org/10.1007/s00393-013-1257-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-013-1257-z

Search

Navigation